pyrroles has been researched along with Hypermelanosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boralevi, F; Fricain, JC; Sibaud, V; Vigarios, E | 1 |
| Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W | 1 |
| Benekli, M; Bilge Yilmaz, I; Buyukberber, S; Coskun, U; Demirci, U; Erdem, O; Ozturk, B | 1 |
| Akanay-Diesel, S; Bölke, E; Budach, W; Erhardt, A; Gerber, PA; Haes, J; Häussinger, D; Hoff, NP; Homey, B; Kürle, S; Matuschek, C; Schulte, KW | 1 |
1 review(s) available for pyrroles and Hypermelanosis
| Article | Year |
|---|---|
[Oral toxicity of targeted anticancer therapies].
Topics: Angiogenesis Inhibitors; Benzamides; ErbB Receptors; Glossitis, Benign Migratory; Humans; Hyperpigmentation; Imatinib Mesylate; Indoles; Maxillary Diseases; Molecular Targeted Therapy; Mouth Mucosa; Osteonecrosis; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrimidines; Pyrroles; Radiation Injuries; Radiotherapy; Stomatitis; Stomatitis, Aphthous; Sunitinib; TOR Serine-Threonine Kinases | 2014 |
3 other study(ies) available for pyrroles and Hypermelanosis
| Article | Year |
|---|---|
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Atorvastatin; Calcium Carbonate; Cardiomyopathy, Restrictive; Citalopram; Connective Tissue Diseases; Diuretics; Female; Furosemide; Glucosamine; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Lupus Erythematosus, Systemic; Magnesium; Metolazone; Middle Aged; Naproxen; Omeprazole; Potassium Chloride; Prednisone; Pyrroles; Selective Serotonin Reuptake Inhibitors; Spironolactone | 2008 |
Acne rosacea associated imatinib mesylate in a gastrointestinal stromal tumor patient.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Biopsy; Gastrointestinal Stromal Tumors; Histamine Antagonists; Humans; Hyperpigmentation; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Keratoderma, Palmoplantar; Liver Neoplasms; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Rosacea; Skin; Skin Pigmentation; Sunitinib; Treatment Outcome | 2011 |
Sunitinib induced pyoderma gangrenosum-like ulcerations.
Topics: Aged; Antineoplastic Agents; Erythema; Humans; Hyperpigmentation; Hypopigmentation; Indoles; Male; Negative-Pressure Wound Therapy; Pyoderma Gangrenosum; Pyrroles; Sunitinib; Ulcer | 2011 |